Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research

What is it about?

The relationship between psychiatric disorders and cannabinoid/vanilloid drugs is increasingly recognized. In fact, exposure to these drugs can be either beneficial or detrimental depending on complex (and overlapped) neuropharmacological mechanisms. Modern neurophysiological tools are now being incorporated into this research topic in order to better inform clinical practice. Mapping this emerging literature and proposing research directions is the aim of this review article.

Featured Image

Why is it important?

With this review, we managed to identify which neurophysiological approaches in rodents will contribute to a better understanding on cannabinoids/vanilloids in schizophrenia.